Position in EYPT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$0
-$242,080 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
11 quarters on record
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Derivatives in EYPT
reported options exposure · as of Mar 31, 2026CallValue
$934,525
CallShares
72,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Caption Management, LLC holds $196,103,961 across 70 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGON |
CG Oncology, Inc.
|
378,480 | $25,615,526 | |
| 2 | IMCR |
Immunocore Holdings plc
|
661,786 | $19,952,847 | |
| 3 | CYTK |
Cytokinetics Inc
|
245,000 | $16,147,950 | |
| 4 | ELVN |
Enliven Therapeutics, Inc.
|
370,000 | $14,504,000 | |
| 5 | SLNO |
Soleno Therapeutics Inc
|
420,143 | $14,066,387 | |
| 6 | CNTA |
Centessa Pharmaceuticals plc
|
274,116 | $10,887,887 | |
| 7 | CORT |
Corcept Therapeutics Inc
|
260,000 | $10,480,600 | |
| 8 | HRMY |
Harmony Biosciences Holdings, Inc.
|
272,292 | $7,626,898 |
All Filings in EYPT
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $934,525 | 72,500 | Call | Sole | 2026-05-15 | |
| 2025-09-30 | $242,080 | 17,000 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $1,708,800 | 120,000 | Put | Sole | 2025-11-14 | |
| 2025-06-30 | $2,073,023 | 220,300 | Put | Sole | 2025-08-14 | |
| 2025-06-30 | $1,125,116 | 119,566 | Shares | Sole | 2025-08-14 | |
| 2024-09-30 | $1,005,861 | 125,890 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $399,500 | 50,000 | Put | Sole | 2024-11-14 | |
| 2024-06-30 | $6,519,780 | 749,400 | Put | Sole | 2024-08-14 | |
| 2024-03-31 | $1,707,342 | 82,600 | Put | Sole | 2024-05-15 | |
| 2024-03-31 | $2,825,589 | 136,700 | Call | Sole | 2024-05-15 | |
| 2023-12-31 | $2,255,536 | 97,600 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $3,466,500 | 150,000 | Call | Sole | 2024-02-14 | |
| 2023-09-30 | $380,324 | 47,600 | Put | Sole | 2023-11-14 | |
| 2022-03-31 | $607,500 | 50,000 | Call | Sole | 2022-05-13 | |
| 2021-12-31 | $2,685,456 | 219,400 | Put | Sole | 2022-02-11 | |
| 2021-12-31 | $4,488,408 | 366,700 | Call | Sole | 2022-02-11 | |
| 2021-09-30 | $1,996,472 | 191,600 | Call | Sole | 2021-11-12 | |
| 2021-09-30 | $424,094 | 40,700 | Put | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||